To better understand the role of various non-KIR NK cell receptors in HSCT and cell therapy, we investigated the association of 1,638 genetic polymorphisms in NK cell receptor genes with relapse and GVHD after HSCT in 1,491 donors from Finland, the UK, Spain, and Poland. The gene discussed is KLRD1; the disease is graft versus host disease.